ORATHECIN Trademark

Trademark Overview

On Tuesday, October 17, 2000, a trademark application was filed for ORATHECIN with the United States Patent and Trademark Office. The USPTO has given the ORATHECIN trademark a serial number of 76149022. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, April 3, 2005. This trademark is owned by SuperGen, Inc.. The ORATHECIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions, namely, drugs for use in the treatment of cancer
orathecin

General Information

Serial Number76149022
Word MarkORATHECIN
Filing DateTuesday, October 17, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, April 3, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 8, 2002

Trademark Statements

Goods and ServicesPharmaceutical compositions, namely, drugs for use in the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 30, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSuperGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSam Ramon, CA 04583
Party NameSuperGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSam Ramon, CA 04583

Trademark Events

Event DateEvent Description
Friday, June 10, 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, June 10, 2005ABANDONMENT - NO USE STATEMENT FILED
Monday, October 4, 2004EXTENSION 5 GRANTED
Friday, September 24, 2004EXTENSION 5 FILED
Friday, September 24, 2004TEAS EXTENSION RECEIVED
Friday, July 23, 2004CASE FILE IN TICRS
Monday, April 26, 2004ASSIGNED TO EXAMINER
Tuesday, March 16, 2004EXTENSION 4 GRANTED
Friday, March 5, 2004EXTENSION 4 FILED
Monday, March 8, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 5, 2004TEAS EXTENSION RECEIVED
Monday, February 23, 2004PAPER RECEIVED
Tuesday, October 28, 2003EXTENSION 3 GRANTED
Monday, September 29, 2003EXTENSION 3 FILED
Monday, September 29, 2003PAPER RECEIVED
Friday, September 5, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 23, 2003EXTENSION 2 GRANTED
Monday, March 31, 2003EXTENSION 2 FILED
Monday, March 31, 2003PAPER RECEIVED
Wednesday, November 13, 2002EXTENSION 1 GRANTED
Wednesday, October 2, 2002EXTENSION 1 FILED
Thursday, October 3, 2002PAPER RECEIVED
Tuesday, April 2, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2002PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2001NOTICE OF PUBLICATION
Wednesday, September 19, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 23, 2001NON-FINAL ACTION MAILED
Thursday, February 22, 2001ASSIGNED TO EXAMINER

Related Keywords

orathecin treatment cancer drugs namely compositions pharmaceutical